A detailed history of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. holds 37,452 shares of PFE stock, worth $1 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
37,452
Previous 37,692 0.64%
Holding current value
$1 Million
Previous $1.05 Million 0.19%
% of portfolio
0.22%
Previous 0.17%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $6,062 - $7,104
-240 Reduced 0.64%
37,452 $1.05 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $440 - $505
17 Added 0.05%
37,692 $1.05 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $73,817 - $95,880
-2,825 Reduced 6.98%
37,675 $1.08 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $63,209 - $73,132
1,750 Added 4.52%
40,500 $1.49 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $11,147 - $14,512
283 Added 0.74%
38,750 $1.58 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $36,865 - $48,123
-883 Reduced 2.24%
38,467 $1.97 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $30,632 - $37,394
-700 Reduced 1.75%
39,350 $1.72 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $85,615 - $101,512
-1,840 Reduced 4.39%
40,050 $2.1 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $38,430 - $47,619
-840 Reduced 1.97%
41,890 $2.17 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $4,132 - $6,125
-100 Reduced 0.23%
42,730 $2.52 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $23,443 - $26,439
700 Added 1.66%
42,830 $1.55 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $78,319 - $99,590
2,340 Added 5.88%
42,130 $1.55 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $691,991 - $811,863
21,795 Added 121.12%
39,790 $1.46 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $63,252 - $76,734
2,100 Added 13.21%
17,995 $588,000
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $2,703 - $3,861
100 Added 0.63%
15,895 $519,000
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $6,584 - $7,472
-200 Reduced 1.25%
15,795 $619,000
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $25,992 - $33,704
800 Added 5.26%
15,995 $575,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $14,791 - $16,608
-400 Reduced 2.56%
15,195 $658,000
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $28,852 - $32,895
750 Added 5.05%
15,595 $681,000
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $25,852 - $31,357
-750 Reduced 4.81%
14,845 $654,000
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $2,143 - $2,285
65 Added 0.42%
15,595 $566,000
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $19,146 - $22,212
600 Added 4.02%
15,530 $551,000
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $121,399 - $128,808
3,650 Added 32.36%
14,930 $541,000
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $349,680 - $385,212
11,280
11,280 $403,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. Portfolio

Follow Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. with notifications on news.